1
|
Joe CCD, Jiang J, Linke T, Li Y, Fedosyuk S, Gupta G, Berg A, Segireddy RR, Mainwaring D, Joshi A, Cashen P, Rees B, Chopra N, Nestola P, Humphreys J, Davies S, Smith N, Bruce S, Verbart D, Bormans D, Knevelman C, Woodyer M, Davies L, Cooper L, Kapanidou M, Bleckwenn N, Pappas D, Lambe T, Smith DC, Green CM, Venkat R, Ritchie AJ, Gilbert SC, Turner R, Douglas AD. Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs. Biotechnol Bioeng 2022; 119:48-58. [PMID: 34585736 PMCID: PMC8653296 DOI: 10.1002/bit.27945] [Citation(s) in RCA: 30] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2021] [Revised: 09/14/2021] [Accepted: 09/21/2021] [Indexed: 12/16/2022]
Abstract
Manufacturing has been the key factor limiting rollout of vaccination during the COVID-19 pandemic, requiring rapid development and large-scale implementation of novel manufacturing technologies. ChAdOx1 nCoV-19 (AZD1222, Vaxzevria) is an efficacious vaccine against SARS-CoV-2, based upon an adenovirus vector. We describe the development of a process for the production of this vaccine and others based upon the same platform, including novel features to facilitate very large-scale production. We discuss the process economics and the "distributed manufacturing" approach we have taken to provide the vaccine at globally-relevant scale and with international security of supply. Together, these approaches have enabled the largest viral vector manufacturing campaign to date, providing a substantial proportion of global COVID-19 vaccine supply at low cost.
Collapse
Affiliation(s)
- Carina C. D. Joe
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | - Jinlin Jiang
- Biopharmaceuticals DevelopmentR&D, AstraZenecaGaithersburgMarylandUSA
| | - Thomas Linke
- Biopharmaceuticals DevelopmentR&D, AstraZenecaGaithersburgMarylandUSA
| | - Yuanyuan Li
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | - Sofiya Fedosyuk
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | - Gaurav Gupta
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | - Adam Berg
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Nicole Bleckwenn
- Biopharmaceuticals DevelopmentR&D, AstraZenecaGaithersburgMarylandUSA
| | - Daniel Pappas
- Biopharmaceuticals DevelopmentR&D, AstraZenecaGaithersburgMarylandUSA
| | - Teresa Lambe
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | | | - Catherine M. Green
- Clinical Biomanufacturing Facility, Nuffield Department of MedicineUniversity of OxfordOxfordUK
| | - Raghavan Venkat
- Biopharmaceuticals DevelopmentR&D, AstraZenecaGaithersburgMarylandUSA
| | - Adam J. Ritchie
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | - Sarah C. Gilbert
- Nuffield Department of Medicine, Jenner InstituteUniversity of OxfordOxfordUK
| | - Richard Turner
- Purification Process Sciences, Biopharmaceuticals DevelopmentR&D, AstraZenecaCambridgeUK
| | | |
Collapse
|
2
|
Handlogten MW, Peng L, Christian EA, Xu W, Lin S, Venkat R, Dall'Acqua W, Ahuja S. Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region. MAbs 2021; 12:1779974. [PMID: 32633193 PMCID: PMC7531514 DOI: 10.1080/19420862.2020.1779974] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
IgG4s are dynamic molecules that undergo a process called Fab-arm exchange. Disulfide bonds between heavy chains are transiently reduced, resulting in half antibodies that reform intact antibodies with other IgG4 half antibodies. In vivo, therapeutic IgG4s can recombine with endogenous IgG4s, resulting in a heterogeneous mixture of bispecific antibodies. A related issue that can occur for any therapeutic protein during manufacturing is interchain disulfide bond reduction. For IgG4s, this primarily results in high levels of half-mAb that persist through purification processes. The S228P mutation has been used to prevent half-mAb formation. However, we demonstrated that IgG4s with the S228P mutation are subject to half-mAb formation and Fab-arm exchange in reducing environments. We identified two novel mutations that stabilize the heavy-heavy chain interaction via incorporation of additional disulfide bonds in the hinge region. Individually, these mutations increase stability toward reduction and lessen Fab-arm exchange. Combination of all three mutations, Y219C, G220C, and S228P, has an additive benefit resulting in an IgG4 with ˃7-fold increase in stability toward reduction while preventing Fab-arm exchange. Importantly, the mutations do not affect antigen binding or Fc effector function. These mutations hold great promise for solving mAb reduction during manufacturing and preventing Fab-arm exchange in vivo.
Collapse
Affiliation(s)
- Michael W Handlogten
- Cell Culture & Fermentation Sciences, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| | - Li Peng
- Antibody Discovery and Protein Engineering, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| | - Elizabeth A Christian
- Analytical Sciences, Bioassay, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| | - Weichen Xu
- Analytical Sciences, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| | - Shihua Lin
- Analytical Sciences, Bioassay, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| | - Raghavan Venkat
- Cell Culture & Fermentation Sciences, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| | - William Dall'Acqua
- Antibody Discovery and Protein Engineering, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| | - Sanjeev Ahuja
- Cell Culture & Fermentation Sciences, Biopharmaceutical Development, AstraZeneca , Gaithersburg, MD, USA
| |
Collapse
|
3
|
Kim J, Luo H, White W, Rees W, Venkat R, Albarghouthi M. Impact of Fc N-linked glycans on in vivo clearance of an immunoglobulin G1 antibody produced by NS0 cell line. MAbs 2020; 12:1844928. [PMID: 33171078 PMCID: PMC7671047 DOI: 10.1080/19420862.2020.1844928] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
The heterogeneity of glycosylation on therapeutic monoclonal antibodies (mAbs) may affect the safety and efficacy of these agents. In particular, glycans of nonhuman origin, such as galactose-alpha-1,3-galactose (gal-α-gal) and N-glycolylneuraminic acid (NGNA), in the Fc region of therapeutic mAbs produced from murine cell lines carry a risk of immunogenicity. Immunogenic glycan structures can have immune-mediated clearance, resulting in faster clearance from in vivo circulation than non-immunogenic structures. To demonstrate the impact of these Fc nonhuman glycans on in vivo clearance, we purified and analyzed the glycan profile of a monoclonal antibody (mAb1) from human serum samples collected from clinical study participants. We purified mAb1 in a three-step chromatographic separation process (protein A, immobilized anti-mAb1 antibody affinity, and weak cation exchange chromatography) and extracted and labeled its N-linked oligosaccharide structures with 2-aminobenzamide acid for analysis on ultrahigh-performance hydrophilic interaction liquid chromatography. A comparison of the glycan profile of mAb1 recovered from human serum on the same day and 4 weeks after dosing revealed no significant differences, indicating similar clearance of mAb1 with nonhuman gal-α-gal or NGNA glycan in the Fc region compared with the human glycans. The relative proportions of the glycans remained similar, and all patients who had already received multiple doses of mAb1 over the course of a year were negative for antidrug antibodies, suggesting that none of the glycans induced an immune response. Therefore, we concluded that mAb1 gal-α-gal and NGNA glycoforms represent a low risk of conferring immunogenicity.
Collapse
Affiliation(s)
- Jun Kim
- BioPharmaceuticals Research and Development, AstraZeneca , Gaithersburg, MD, USA
| | - Haibin Luo
- BioPharmaceuticals Research and Development, AstraZeneca , Gaithersburg, MD, USA
| | - Wendy White
- BioPharmaceuticals Research and Development, AstraZeneca , Gaithersburg, MD, USA
| | - William Rees
- Research and Development, Viela Bio , Gaithersburg, MD, USA
| | - Raghavan Venkat
- BioPharmaceuticals Research and Development, AstraZeneca , Gaithersburg, MD, USA
| | - Methal Albarghouthi
- BioPharmaceuticals Research and Development, AstraZeneca , Gaithersburg, MD, USA
| |
Collapse
|
4
|
Venkat R, Adchaya AS, Muthukumar B, Manipal S. In-Vitro Study to Check the Viability of Fixed Partial Dentures with Built-in Passive RFIDs- A Forensic Dentistry Tool. J Clin Diagn Res 2019. [DOI: 10.7860/jcdr/2019/42412.13186] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
5
|
Handlogten MW, Lee-O'Brien A, Roy G, Levitskaya SV, Venkat R, Singh S, Ahuja S. Intracellular response to process optimization and impact on productivity and product aggregates for a high-titer CHO cell process. Biotechnol Bioeng 2017; 115:126-138. [DOI: 10.1002/bit.26460] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2017] [Revised: 08/19/2017] [Accepted: 09/19/2017] [Indexed: 12/24/2022]
Affiliation(s)
| | - Allison Lee-O'Brien
- Cell Culture and Fermentation Sciences; MedImmune LLC; Gaithersburg Maryland
| | - Gargi Roy
- Antibody Discovery and Protein Engineering; MedImmune LLC; Gaithersburg Maryland
| | | | - Raghavan Venkat
- Cell Culture and Fermentation Sciences; MedImmune LLC; Gaithersburg Maryland
| | - Shailendra Singh
- Biologics Development and Commercialization; West Point Pennsylvania
| | - Sanjeev Ahuja
- Cell Culture and Fermentation Sciences; MedImmune LLC; Gaithersburg Maryland
| |
Collapse
|
6
|
Lee JH, Reier J, Heffner KM, Barton C, Spencer D, Schmelzer AE, Venkat R. Production and characterization of active recombinant human factor II with consistent sialylation. Biotechnol Bioeng 2017; 114:1991-2000. [DOI: 10.1002/bit.26317] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2016] [Revised: 04/04/2017] [Accepted: 04/17/2017] [Indexed: 11/10/2022]
Affiliation(s)
- Jeong H. Lee
- Biopharmaceutical Development; MedImmune; 1 MedImmune Way Gaithersburg 20878 Maryland
| | - Jason Reier
- Biopharmaceutical Development; MedImmune; 1 MedImmune Way Gaithersburg 20878 Maryland
| | - Kelley M. Heffner
- Department of Chemical and Biomolecular Engineering; Johns Hopkins University; Baltimore Maryland
| | | | - David Spencer
- Ipsen Biopharm Limited; Wrexham Industrial Estate, Wrexham United Kingdom
| | - Albert E. Schmelzer
- Biopharmaceutical Development; MedImmune; 1 MedImmune Way Gaithersburg 20878 Maryland
| | - Raghavan Venkat
- Biopharmaceutical Development; MedImmune; 1 MedImmune Way Gaithersburg 20878 Maryland
| |
Collapse
|
7
|
Venkat R, Vasanthakumar M, Balakrishnan D, Deenadayalan P. Upper airway dimensions and sleep efficiency--three-dimensional imaging analysis and assessment of the nasopharyngeal appliance. Indian J Dent Res 2015; 26:451-61. [PMID: 26672413 DOI: 10.4103/0970-9290.172021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
BACKGROUND Reduction of upper airway (UA) dimensions during sleep is contemplated to cause reduced sleep efficiency (SE) but a definitive association is not affirmed. Efficacy of nasopharyngeal appliance (NPA) in management of UA resistance syndrome (UARS) has not been compared with mandibular repositioning splint (MRS). This study intended to assess relation of UA dimensions to SE and effectiveness of NPA. MATERIALS AND METHODS Research had two phases: Case-control study to determine association between UA and SE; randomized control trial (with independent concurrent trial groups and double-blind design) to analyze treatment outcome with NPA. Subjects were categorized to three groups of 20 in each: A control group of healthy subjects (Group A); two "Randomly Assigned" sample groups of subjects with reduced SE (Groups B and C). Preliminary questionnaire for sleep analysis, Final data collection sheet (first and second case sheets) were recorded, cephalometric variables analyzed, and diagnostic overnight polysomnography was done to match and confirm selection criteria. Three-dimensional computed tomography was done to analyze airway dimensions before and after appliance placement. ANOVA and post-hoc tests were used for statistical analysis of results. CONCLUSIONS Reduced UA dimension during sleep is associated with reduced SE; NPA gives better improvement for UARS than MRS.
Collapse
Affiliation(s)
- R Venkat
- Department of Prosthodontics, SRM Dental College, SRM University, Ramapuram, Chennai, Tamil Nadu, India
| | | | | | | |
Collapse
|
8
|
Evans K, Albanetti T, Venkat R, Schoner R, Savery J, Miro-Quesada G, Rajan B, Groves C. Assurance of monoclonality in one round of cloning through cell sorting for single cell deposition coupled with high resolution cell imaging. Biotechnol Prog 2015; 31:1172-8. [PMID: 26195345 PMCID: PMC5054913 DOI: 10.1002/btpr.2145] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2015] [Revised: 06/08/2015] [Indexed: 12/17/2022]
Abstract
Regulatory authorities require that cell lines used in commercial production of recombinant proteins must be derived from a single cell progenitor or clone. The limiting dilution method of cell cloning required multiple rounds of low-density cell plating and microscopic observation of a single cell in order to provide evidence of monoclonality. Other cloning methods rely on calculating statistical probability of monoclonality rather than visual microscopic observation of cells. We have combined the single cell deposition capability of the Becton Dickinson Influx™ cell sorter with the microscopic imaging capability of the SynenTec Cellavista to create a system for producing clonal production cell lines. The efficiency of single cell deposition by the Influx™ was determined to be 98% using fluorescently labeled cells. The centrifugal force required to settle the deposited cells to the bottom of the microplate well was established to be 1,126g providing a 98.1% probability that all cells will be in the focal plane of the Cellavista imaging system. The probability that a single cell was deposited by the cell sorter combined with the probability of every cell settling into the focal plane of the imager yield a combined >99% probability of documented monoclonality.
Collapse
Affiliation(s)
- Krista Evans
- Cell Culture and Fermentation Sciences, Biopharmaceutical Development, MedImmune, Gaithersburg, MD , 20878
| | - Thomas Albanetti
- Cell Culture and Fermentation Sciences, Biopharmaceutical Development, MedImmune, Gaithersburg, MD , 20878
| | - Raghavan Venkat
- Cell Culture and Fermentation Sciences, Biopharmaceutical Development, MedImmune, Gaithersburg, MD , 20878
| | - Ronald Schoner
- Cell Culture and Fermentation Sciences, Biopharmaceutical Development, MedImmune, Gaithersburg, MD , 20878
| | - James Savery
- Data Management and Quantitative Sciences, MedImmune, Gaithersburg, MD , 20878
| | | | - Bhargavi Rajan
- Respiratory, Inflammation and Autoimmunity, MedImmune, Gaithersburg, MD , 20878
| | - Christopher Groves
- Respiratory, Inflammation and Autoimmunity, MedImmune, Gaithersburg, MD , 20878
| |
Collapse
|
9
|
Venkat R, Gopichander N, Vasantakumar M. Comprehensive analysis of repair/reinforcement materials for polymethyl methacrylate denture bases: mechanical and dimensional stability characteristics. J Indian Prosthodont Soc 2014; 13:439-49. [PMID: 24431773 DOI: 10.1007/s13191-012-0249-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2012] [Accepted: 12/29/2012] [Indexed: 11/26/2022] Open
Abstract
Fracture of complete denture is a common problem as acrylic resins hold inherent limitations. This necessitates affirmation of a selection criterion by evaluating the critical requirements of repair materials. The study intended to evaluate mechanical properties and dimensional stability of common denture base repair and reinforcement materials under standard experimental protocol. Seven types of denture reinforcement materials were chosen. Forty cuboidal samples were made in accordance with ISO 178 for three point bending test and divided to eight groups of five samples each. One group acted as control and samples of seven groups were sectioned and repaired with chosen materials. Five mechanical properties-fracture load, deflection, flexural strength, fracture toughness and elastic modulus were evaluated for all groups. Forty mandibular complete denture specimens were utilized for evaluating fracture load and deflection under loading. Dimensional stability after repair with seven different repair materials was analyzed in two planes (Linear and curvilinear) utilizing separate set of denture samples. Heat cure polymethyl methacrylate with polyethylene fiber was affirmed as material of choice based on this study as it accomplishes the most critical norms of requirement.
Collapse
Affiliation(s)
- R Venkat
- Department of Prosthodontics, SRM Dental College, Ramapuram, Chennai, 600089 India
| | - N Gopichander
- Department of Prosthodontics, SRM Dental College, Ramapuram, Chennai, 600089 India ; 496, 3rd Main Road, TNHB Colony, Velachery, Chennai, 600042 India
| | - M Vasantakumar
- Department of Prosthodontics, SRM Dental College, Ramapuram, Chennai, 600089 India
| |
Collapse
|
10
|
Gopi Chander N, Venkat R. An appraisal on increasing the occlusal vertical dimension in full occlusal rehabilitation and its outcome. J Indian Prosthodont Soc 2012; 11:77-81. [PMID: 22654346 DOI: 10.1007/s13191-011-0066-9] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2010] [Accepted: 02/03/2011] [Indexed: 11/29/2022] Open
Abstract
Increasing the occlusal vertical dimension for gaining sufficient restoration space in the management of severely worn dentition is being practiced. This contentious belief has lead to challenging thoughts regarding its effects on the Odonto-stomatognathic system. There are basic uncertainties and existing erroneous thoughts regarding the perception of increasing the occlusal vertical dimension. This manuscript will review the bite raising concepts and its outcome on the stomatognathic system.
Collapse
Affiliation(s)
- N Gopi Chander
- Department of Prosthodontics, SRM Dental College, Bharathy Salai, Ramapuram, Chennai, 600 089 India
| | | |
Collapse
|
11
|
Goel A, Venkat R, Kumar A, Adkoli BV, Sood R. Structured internship orientation programme for undergraduate students: easy transition to clinical work. Natl Med J India 2010; 23:160-162. [PMID: 20949721] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
BACKGROUND Internship is a phase of training when a new graduate is expected to acquire skills under supervision, so that he/she may become capable of functioning independently. Often, new graduates go through this period without a clear aim. We conducted an orientation programme before fresh graduates started their 1-year internship to familiarize them with their clinical tasks and their role in the community. METHODS Interns were invited to participate in a one-and-a-half day programme conducted by faculty members and administrators that included interactive lectures, structured panel discussions, group discussions and role plays. The participants provided feedback using a structured questionnaire and during informal group discussions. They were also evaluated by a pre-test and post-test questionnaire. RESULTS Of the 41 interns who attended the programme on day 1 and the 28 who completed it on day 2, 19 completed the post-test questionnaire. The post-test score (median 14.5; range 10-18) represented a significant improvement over the pre-test score (median 13, range 3-16). All participants felt that the workshop was successful in achieving its objectives. CONCLUSION A brief and structured orientation programme before internship offers a practical means of making the transition of new graduates from students to practising doctors smoother.
Collapse
Affiliation(s)
- Ashish Goel
- Department of Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
| | | | | | | | | |
Collapse
|
12
|
Gopichander N, Vasantakumar M, Venkat R. Four novel prosthodontic methods for managing upper airway resistance syndrome: An investigative analysis revealing the efficacy of the new nasopharyngeal aperture guard appliance. Indian J Dent Res 2010; 21:44-8. [DOI: 10.4103/0970-9290.62812] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
13
|
Lu J, Weiss E, Zheng D, Rosu M, Hugo G, Venkat R, Gopalan S, Williamson J, Keall P. TH-D-BRC-07: Impact of Respiratory Biofeedback On Adaptively Sampled 4D-CBCT Image Quality: Initial Experiences. Med Phys 2009. [DOI: 10.1118/1.3182680] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
14
|
Suh Y, Sawant A, Venkat R, Keall P. 4D IMRT Planning Based on a DMLC Motion Tracking Algorithm. Int J Radiat Oncol Biol Phys 2008. [DOI: 10.1016/j.ijrobp.2008.06.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Smith R, Sawant A, Santanam L, Venkat R, Newell J, Cho B, Poulsen P, Catell H, Keall P, Parikh P. IMRT Dosimetric Measurements from a Real-time Internal Position Monitoring System Coupled with a Dynamic Multileaf Collimator Tracking System. Int J Radiat Oncol Biol Phys 2008. [DOI: 10.1016/j.ijrobp.2008.06.244] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
Keall P, Cho B, Poulsen P, Sawant A, Suh Y, Venkat R. TU-EE-A3-05: Simultaneous Tracking and Four-Dimensional Radiotherapy Delivery: Accounting for Spatial and Morphological Tumor Changes. Med Phys 2008. [DOI: 10.1118/1.2962621] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
17
|
Gadgeel SM, Ruckdeschel JC, Wozniak A, Patel B, Heilbrun LK, Chen W, Venkat R, Chaplen R, Turrisi A. Pemetrexed and cisplatin with concurrent thoracic radiation therapy (TRT) followed by docetaxel in stage III non-small cell lung cancer (NSCLC) patients (pts). J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.7569] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
18
|
Sahasrabudhe SR, Lai S, Pierce M, Clemens C, Venkat R, Rebentisch M, Senina A, Becklin R, Richards SK, Erkkila T, Robbins PB. Selective in vitro and in vivo anti-tumor activity of PRLX 93936 in biological models of melanoma and ovarian cancer. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.14586] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
19
|
Chander G, Vasantakumar M, Venkat R. Ersatz Gingiva. J Indian Prosthodont Soc 2008. [DOI: 10.4103/0972-4052.43646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
20
|
Sawant A, Keall P, Srivastava V, Venkat R, Cattell H, Povzner S, Carlson D. TU-FF-A3-04: Empirical Investigation of 3D Intrafraction Motion Management Using a Generalized Methodology for Tracking Translating, Rotating and Deforming Targets. Med Phys 2007. [DOI: 10.1118/1.2761446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
21
|
Abstract
Circulatory support devices require 10-20 W. Currently, several devices are under development for the transmission of this power via transcutaneous transformers, with the secondary implanted subcutaneously and the primary worn externally. Because these devices are air cored, they have relatively large, bulky external appliances, poor coil to coil coupling, and result in significant stray fields passing through adjacent tissues. This article reports on the engineering design of a novel, high permeability cored transformer implanted in a transenteric configuration using an isolated intestinal pouch. Such an approach offers greater energy transmission efficiency, less heat dissipation, less stray electromagnetic energy, and greatly reduced device size. Two competing designs using this concept have been developed and tested. Each consists of the transformer, together with power interface electronics, forming a direct current (DC)/DC resonant converter. Operating frequencies are 90.2 and 14.7 kHz, respectively, with primary/secondary turns ratios of 10/10 and 11/14, respectively. In addition, data interface electronics allows communication across the transformer of up to four signals at a per channel sample rate of 10 Hz. Both designs are able to continuously transmit 25 W at an output level of 12 Vdc into a 5.8 omega load. Calorimetry tests indicate DC to DC efficiencies greater than 75% and coil to coil efficiencies greater than 96%. Total package size for the implantable portion of each device (including sensor internal interface electronics) is less than 40 ml, with a weight weight of less than 100 g. The results of short-term implantation studies have been favorable. Long-term implantation studies currently are under way.
Collapse
Affiliation(s)
- A J Helmicki
- Department of Electrical and Computer Engineering, University of Cincinnati, OH 45221-0030, USA
| | | | | | | | | | | |
Collapse
|